These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2970853)

  • 1. Isradipine (PN 200-110) versus hydrochlorothiazide in mild to moderate hypertension. A multicenter study.
    Mohanty PK; Gonasun LM; Goodman RP; Kirkendal WM; Kontos HA; Samuel P; Wright JT
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):241S-244S. PubMed ID: 2970853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of essential hypertension with PN 200-110 (isradipine).
    Hamilton BP
    Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA; Glasser SP; Ram CV; McMahon SG; Vanov SK; Leibowitz DA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R; Mugellini A; Derosa G;
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
    J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiapamil and hydrochlorothiazide: a double-blind comparison of two antihypertensive agents.
    Storm TL; Badskjaer J; Hammer R; Kögler P
    J Clin Pharmacol; 1987 Jan; 27(1):18-21. PubMed ID: 3316301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension.
    Burris JF; Ames RP; Applegate WB; Ram CV; Davidov ME; Mroczek WJ
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S98-102. PubMed ID: 2467140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension.
    Neutel JM; Franklin SS; Lapuerta P; Bhaumik A; Ptaszynska A
    J Hum Hypertens; 2008 Apr; 22(4):266-74. PubMed ID: 17928878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
    Grassi G; Seravalle G; Brambilla G; Dell'Oro R; Trevano FQ; Fici F; van Bortel L; Mancia G
    Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension.
    Rofman BA
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S94-7. PubMed ID: 2467139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.
    Koenig W; Sund M; Binner L; Hehr R; Rosenthal J; Hombach V
    Eur J Clin Pharmacol; 1991; 41(3):197-9. PubMed ID: 1748135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.